Skip to main content
RPbio Inc. logo

RPbio Inc. — Investor Relations & Filings

Ticker · 314140 ISIN · KR7314140005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2023-06-16 Regulatory Filings
Country KR South Korea
Listing KO 314140

About RPbio Inc.

https://rpbio.co.kr/html/en/main.php

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM) to discuss board changes. It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory notice of the meeting's administrative preparation. Given the nature of the announcement and the lack of a more specific category for meeting preparation notices, it falls under the general regulatory filing category.
2023-06-16 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a shareholder meeting (주주총회소집결의) for Alpi Bio, detailing the date, location, and agenda items, specifically the appointment of an auditor. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of upcoming voting matters.
2023-06-16 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for RP Bio, covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial information, business operations, management discussions, and capital structure data. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2023
2023-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) dated 2023-03-31. It details the outcomes of the meeting, including the approval of financial statements, director/auditor compensation limits, and other agenda items. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports the official results of shareholder votes at a general meeting.
2023-03-31 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 7th fiscal year (2022) of RP Bio. It contains detailed company information, history, capital changes, business overview, product details, and production data. This is a comprehensive annual financial and operational report required by the Financial Supervisory Service (FSS) in South Korea, which corresponds to the 10-K filing category in the provided schema. FY 2022
2023-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Alpi Bio. It provides the audit opinion, key financial data, and auditor information as required by the Korea Exchange (KRX). While it contains financial data, it is a summary announcement of the audit report submission rather than the full, multi-page annual report document itself. Therefore, it fits the definition of a Regulatory Filing (RNS) as it is a standard disclosure announcement. FY 2022
2023-03-22 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.